| Acral Melanoma studied in …STUDIED_INderived29 of 29show fewer |
|---|
| → studied in | NCT07576725Phase 2 · not yet recruiting Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial · condition mapped CURATED_BROADER · 29 trials mapped (16 active) | — | — | Acral Lentiginous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04462406Phase 2 · active not recruiting Using Biomarkers to Help Guide Safe Immunotherapy Discontinuation in Patients With Unresectable Stage IIIB-IV Melanoma, The PET-Stop Trial · condition mapped CURATED_BROADER · 29 trials mapped (16 active) | — | — | Acral Lentiginous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04511013Phase 2 · recruiting A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases · condition mapped ONTOLOGY_EXACT · 29 trials mapped (16 active) | — | — | Acral Lentiginous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00937937Phase 2 · active not recruiting Dinaciclib in Treating Patients With Stage IV Melanoma · condition mapped ONTOLOGY_EXACT · 29 trials mapped (16 active) | — | — | Acral Lentiginous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03025256Phase 1 · active not recruiting Intravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal Disease · condition mapped ONTOLOGY_EXACT · 29 trials mapped (16 active) | — | — | Acral Lentiginous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03698019Phase 2 · active not recruiting A Study to Compare the Administration of Pembrolizumab After Surgery Versus Administration Both Before and After Surgery for High-Risk Melanoma · condition mapped ONTOLOGY_EXACT · 29 trials mapped (16 active) | — | — | Acral Lentiginous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05098210Phase 1 · recruiting Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer · condition mapped CURATED_BROADER · 29 trials mapped (16 active) | — | — | Acral Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05628883Phase 1 · completed Proof of Concept of TBio-4101, Lymphodepleting Chemo, IL-2 for Relapsed/Refractory Melanoma · condition mapped ONTOLOGY_EXACT · 29 trials mapped (16 active) | — | — | Acral Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04119024Phase 1 · recruiting Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors · condition mapped ONTOLOGY_EXACT · 29 trials mapped (16 active) | — | — | Acral Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07347444Phase 2 · not yet recruiting Iparomlimab and Tuvoraleimab Injection in Combination With Bevacizumab, Albumin-bound Paclitaxel, and Carboplatin as First- or Second-line Treatment for Patients With Advanced Acral and Mucosal Melanoma · condition mapped ONTOLOGY_EXACT · 29 trials mapped (16 active) | — | — | Acral Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07155317Phase 2 · recruiting Time-of-Day Specified Immunotherapy for Advanced Melanoma, The TIME Trial · condition mapped CURATED_BROADER · 29 trials mapped (16 active) | — | — | Acral Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05086692Phase 1/Phase 2 · recruiting A Beta-only IL-2 ImmunoTherapY Study · condition mapped ONTOLOGY_EXACT · 29 trials mapped (16 active) | — | — | Acral Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06965231Phase 2 · recruiting Perioperative Toripalimab and Endostatin for Stage II Melanoma: A Phase II Trial · condition mapped ONTOLOGY_EXACT · 29 trials mapped (16 active) | — | — | Acral Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02875132Phase 2 · completed Pembrolizumab in Advanced/Metastatic Acral Lentiginous Melanoma · condition mapped ONTOLOGY_EXACT · 29 trials mapped (16 active) | — | — | Acral Lentiginous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05436990Phase 2 · terminated Antitumor Activity of Vactosertib in Combination With Pembrolizumab in Acral and Mucosal Melanoma Patients Progressed From Prior Immune Check Point Inhibitor · condition mapped ONTOLOGY_EXACT · 29 trials mapped (16 active) | — | — | Acral Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05512481Phase 2 · recruiting Camrelizumab Plus Apatinib and Temozolomide as Neoadjuvant in High Risk Acral Melanoma · condition mapped ONTOLOGY_EXACT · 29 trials mapped (16 active) | — | — | Acral Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06661577not yet recruiting An Observational Study Using The LumAssure Device In Participants Undergoing Assessment Of Skin Conditions. · condition mapped ONTOLOGY_EXACT · 29 trials mapped (16 active) | — | — | Acral Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02519322Phase 2 · completed Neoadjuvant and Adjuvant Checkpoint Blockade · condition mapped CURATED_BROADER · 29 trials mapped (16 active) | — | — | Acral Lentiginous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02978443Phase 2 · terminated A Biomarker Study in Advanced Mucosal or Acral Lentiginous Melanoma Receiving Nivolumab in Combination With Ipilimumab · condition mapped ONTOLOGY_EXACT · 29 trials mapped (16 active) | — | — | Acral Lentiginous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04244552Phase 1 · terminated A Phase 1b Trial of ATRC-101 in Adults With Advanced Solid Malignancies · condition mapped ONTOLOGY_EXACT · 29 trials mapped (16 active) | — | — | Acral Lentiginous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05789043Phase 3 · recruiting Camrelizumab in Combination With Apatinib and Temozolomide as First-line Treatment in Advanced Acral Melanoma · condition mapped ONTOLOGY_EXACT · 29 trials mapped (16 active) | — | — | Acral Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04331093Phase 2 · recruiting Neoadjuvant SHR-1210 Plus Apatinib for Resectable Stage III-IV Acral Melanoma · condition mapped ONTOLOGY_EXACT · 29 trials mapped (16 active) | — | — | Acral Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00788775Phase 2 · completed Nilotinib in TKI Resistant or Intolerant Patients With Metastatic Mucosal, Acral, or Chronically Sun Damaged Melanoma · condition mapped ONTOLOGY_EXACT · 29 trials mapped (16 active) | — | — | Acral Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00243061Phase 2 · completed AZD2171 in Treating Patients With Recurrent or Stage IV Melanoma · condition mapped ALIAS · 29 trials mapped (16 active) | — | — | Acral Lentiginous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01395121Phase 2 · completed A Trial Looking at Nilotinib to Treat Acral and Mucosal Melanoma Skin Cancer That Has Spread · condition mapped ALIAS · 29 trials mapped (16 active) | — | — | Acral Lentiginous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00424515Phase 2 · completed Imatinib in Patients With Mucosal or Acral/Lentiginous Melanoma · condition mapped ONTOLOGY_EXACT · 29 trials mapped (16 active) | — | — | Acral Lentiginous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00577382Phase 2 · completed SU011248 in Patients With Metastatic Mucosal or Acral/Lentiginous Melanoma · condition mapped ALIAS · 29 trials mapped (16 active) | — | — | Acral Lentiginous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01120275Phase 2 · terminated Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Stage IV Melanoma · condition mapped ALIAS · 29 trials mapped (16 active) | — | — | Acral Lentiginous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00470470Phase 2 · completed Imatinib Mesylate in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery · condition mapped ALIAS · 29 trials mapped (16 active) | — | — | Acral Lentiginous Melanoma | 1 | Observed | clinicaltrials | graph → |